E Fund Management’s Day One Biopharmaceuticals DAWN Stock Holding History

E Fund Management’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$71.4K	Sell	10,988 -148	-1%	-$1.02K	﹤0.01%	383
2025 Q1	$88.3K	Sell	11,136 -140	-1%	-$1.51K	﹤0.01%	387
2024 Q4	$143K	Buy	+11,276	New	+$157K	0.01%	373
2024 Q1	–	Sell	-12,618	Closed	-$184K	–	373
2023 Q4	$184K	Buy	12,618 +442	+4%	+$5.36K	0.01%	291
2023 Q3	$149K	Sell	12,176 -3,465	-22%	-$45.2K	0.01%	272
2023 Q2	$187K	Buy	15,641 +4,774	+44%	+$62.4K	0.01%	284
2023 Q1	$145K	Buy	10,867 +103	+1%	+$2.01K	0.01%	312
2022 Q4	$232K	Buy	+10,764	New	+$221K	0.02%	276

Other funds holding DAWN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

E Fund Management's DAWN Position: Q2 2025 in Review

E Fund Management reduced its Day One Biopharmaceuticals (DAWN) stake by 1.3% in Q2 2025, selling an estimated $1.02K and leaving 10,988 shares worth $71.4K. The position accounts for ﹤0.01% of the portfolio, ranked #383.

E Fund Management first reported a position in DAWN in Q4 2022 and has held it in 8 quarters since. The position peaked at $232K in Q4 2022. 174 funds tracked by Wall St. Rank hold DAWN as of Q2 2025.

E Fund Management held 10,988 shares of Day One Biopharmaceuticals worth $71.4K as of Q2 2025.
E Fund Management sold 148 Day One Biopharmaceuticals shares in Q2 2025, an estimated $1.02K.
Day One Biopharmaceuticals made up ﹤0.01% of E Fund Management's portfolio in Q2 2025, its #383 holding.
E Fund Management first reported a position in Day One Biopharmaceuticals in Q4 2022 and has held it in 8 quarters since.
E Fund Management's Day One Biopharmaceuticals position peaked at $232K in Q4 2022.
174 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2025.

Based on E Fund Management's 13F filing for Q2 2025, filed 15 Aug 2025.